--(www.USEquityNews.com)-- 11/19/2007 - Pharmaceutical industry alert provided by U.S. Equity News. Drug maker Amgen Inc. (NASDAQ: AMGN) hired Sally Katzen, a former deputy director at the White House budget office during the Clinton administration, to lobby the federal government, according to a disclosure form. Katzen will lobby on Medicare coverage and reimbursement issues, according to the form posted online recently by the Senate's public records office. Katzen, who has been teaching law at several universities, also served as deputy assistant to President Clinton for economy policy and deputy director of the National Economic Council.
Shares of biotechnology company Genzyme Corp. (NASDAQ: GENZ) rose recently after billionaire investor Carl Icahn snapped up more than 1 million shares, fueling investor speculation of a potential buyout. The Cambridge, Mass. company's stock rose $2.08, or 2.9 percent, to end at $72.84. Its stock has ranged between $58.71 and $76.90 over the past year.
Biotechnology company Gilead Sciences Inc. (NASDAQ: GILD) said recently it has asked the Food and Drug Administration to approve its aztreonam lysine inhaled cystic fibrosis treatment. The drug is intended to be administered three times per day, at 75-milligram doses. Cystic fibrosis is a chronic, genetic disease in which thick, sticky mucus in the lungs traps bacteria, predisposing patients to lung infections.
Aida Pharmaceuticals, Inc. (OTCBB: AIDA) recently announced that it has filed its form 10Q for the period ended September 30, 2007. Net revenues totaled $7,373,770 for the quarter ended 9/20/07, an increase of 5% over the same period in 2006. Gross profit decreased by 2.66% due to an increase in Costs of Goods Sold. Most notably, sales from Aida's transfusion and injection forms of etimicin sulfate increased markedly.
About U.S. Equity News
U.S. Equity News provides information, resources and news services for investors of small-cap, micro-cap and emerging companies. U.S. Equity News distributes RSS news feeds and a free subscription-based newsletter available through its website at www.usequitynews.com.
U.S. Equity News is a financial news distribution service by Equity Solutions, Inc. (www.equityirsolutions.com) that provides a platform for public companies to disseminate important news to key Wall Street interest such as shareholders and new investors. Equity Solutions, Inc. can assist by providing an effective increase in the awareness of a public company's news, development and corporate story through its proprietary network and its financial portal. U.S. Equity News and its affiliates charge each client cash for news distribution and may take an equity position in the companies mentioned herein, please visit the disclaimer at www.USEquityNews.com.